Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 6, 2010, Pages 2689-2698

  Lépine, Johanie ^a   Audet Walsh, Etienne ^a   Grégoire, Jean ^a   Têtu, Bernard ^a   Plante, Marie ^a   Ménard, Vincent ^a   Ayotte, Pierre ^b   Brisson, Jacques ^b   Caron, Patrick ^a   Villeneuve, Lyne ^a   Bélanger, Alain ^a   Guillemette, Chantal ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; ESTRONE SULFATE; GLUCURONOSYLTRANSFERASE; RNA; TESTOSTERONE 17BETA DEHYDROGENASE; COMPLEMENTARY DNA; DEOXYRIBONUCLEASE; ENZYME; ESTROGEN; HYDROXYSTEROID DEHYDROGENASE; SEX HORMONE; SULFATASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; BLOOD; CHEMISTRY; COMPARATIVE STUDY; ENDOMETRIUM; ENDOMETRIUM TUMOR; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

17-HYDROXYSTEROID DEHYDROGENASES; AGED; DEOXYRIBONUCLEASES; DNA, COMPLEMENTARY; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ENZYMES; ESTROGENS; FEMALE; GLUCURONOSYLTRANSFERASE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SULFATASES;

EID: 77954506419     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2648     Document Type: Article

References (44)

1. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, Peeters PH, Onland-Moret NC, Lahmann PH, Berrino F, Panico S, Larrañaga N, Pera G, Tormo MJ, Sanchez MJ, Ramón Quirós J, Ardanaz E, Tjønneland A, Olsen A, Chang-Claude J, Linseisen J, Schulz M, Boeing H, Lundin E, Palli D, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Bingham S, Khaw KT, Bas Bueno-de-Mesquita H, Trichopoulou A, Trichopoulos D, Naska A, Tumino R, Riboli E, Kaaks R 2008 Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 15:485-497
2. Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, Berrino F, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A 2004 Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108:425-432
3. Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, Koenig KL, Shore RE, Kim MY, Levitz M, Mittal KR, Raju U, Banerjee S, Toniolo P 2001 Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 84:975-981
4. Bokhman JV 1983 Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17
5. Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR 1996 Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 88:1127-1135 (Pubitemid 26274607)
6. Nyholm HC, Nielsen AL, Lyndrup J, Dreisler A, Hagen C, Haug E 1993 Plasma oestrogens in postmenopausal women with endometrial cancer. Br J Obstet Gynaecol 100:1115-1119 (Pubitemid 24003622)
7. Tuckerman EM, Okon MA, Li T, Laird SM 2000 Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 74:771-779
8. Zang H, Sahlin L, Masironi B, Eriksson E, Lindén Hirschberg A 2007 Effects of testosterone treatment on endometrial proliferation in postmenopausal women. J Clin Endocrinol Metab 92:2169-2175
9. Utsunomiya H, Ito K, Suzuki T, Kitamura T, Kaneko C, Nakata T, Niikura H, Okamura K, Yaegashi N, Sasano H 2004 Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. Clin Cancer Res 10:5850-5856
10. Husen B, Psonka N, Jacob-Meisel M, Keil C, Rune GM 2000 Differential expression of 17β-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines. J Mol Endocrinol 24:135-144 (Pubitemid 30117667)
11. Luu-The V, Tremblay P, Labrie F 2006 Characterization of type 12 17β-hydroxysteroid dehydrogenase, an isoform of type 3 17β- hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol Endocrinol 20:437-443
12. Utsunomiya H, Suzuki T, Kaneko C, Takeyama J, Nakamura J, Kimura K, Yoshihama M, Harada N, Ito K, Konno R, Sato S, Okamura K, Sasano H 2001 The analyses of 17β-hydroxysteroid dehydrogenase isozymes inhumanendometrial hyperplasia and carcinoma. J Clin Endocrinol Metab 86:3436-3443
13. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT 2003 Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 144:3382-3398
14. Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya R 2003 CYP1B1 gene in endometrial cancer. Mol Cell Endocrinol 202:171-176
15. Vadlamuri SV, Glover DD, Turner T, Sarkar MA 1998 Regiospecific expression of cytochrome P4501A1 and 1B1 in human uterine tissue. Cancer Lett 122:143-150
16. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, Rogan EG 1997 Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 94:10937-10942
17. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT 1995 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 92:9220-9224
18. Bai HW, Shim JY, Yu J, Zhu BT 2007 Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chem Res Toxicol 20:1409-1425
19. Falany JL, Azziz R, Falany CN 1998 Identification and characterization of cytosolic sulfotransferases in normal human endometrium. Chem Biol Interact 109:329-339
20. Smuc T, Rupreht R, Sinkovec J, Adamski J, Rizner TL 2006 Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer. Mol Cell Endocrinol 248:114-117
21. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E 1994 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964-3968 (Pubitemid 24139553)
22. Lakhani NJ, Sarkar MA, Venitz J, Figg WD 2003 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23:165-172
23. Guillemette C 2003 Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 3:136-158
24. Guillemette C, Bélanger A, Lépine J 2004 Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res 6:246-254
25. Lépine J, Bernard O, Plante M, Têtu B, Pelletier G, Labrie F, Bélanger A, Guillemette C 2004 Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 89:5222-5232
26. Duguay Y, McGrath M, Lépine J, Gagné JF, Hankinson SE, Colditz GA, Hunter DJ, Plante M, Têtu B, Bélanger A, Guillemette C, De Vivo I 2004 The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res 64:1202-1207
27. Lévesque E, Beaulieu M, Green MD, Tephly TR, Bélanger A, Hum DW1997 Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325
28. Thibaudeau J, Lépine J, Tojcic J, Duguay Y, Pelletier G, Plante M, Brisson J, Têtu B, Jacob S, Perusse L, Bélanger A, Guillemette C 2006 Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Res 66:125-133
29. Turgeon D, Carrier JS, Lévesque E, Hum DW, Bélanger A 2001 Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787 (Pubitemid 32222427)
30. Green MD, Oturu EM, Tephly TR 1994 Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 22:799-805
31. Liehr JG 2000 Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21:40-54
32. Sandanger TM, Sinotte M, Dumas P, Marchand M, Sandau CD, Pereg D, BérubéS, Brisson J, Ayotte P 2007 Plasma concentrations of selected organobromine compounds and polychlorinated biphenyls in postmenopausal women of Québec, Canada. Environ Health Perspect 115:1429-1434
33. Labrie F, Bélanger A, Bélanger P, BérubéR, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J 2007 Metabolism of DHEA in postmenopausal women following percutaneous administration. J Steroid Biochem Mol Biol 103:178-188
34. Blake J 2006 Menopause: evidence-based practice. Best Pract Res Clin Obstet Gynaecol 20:799-839
35. Song D, Liu G, Luu-The V, Zhao D, Wang L, Zhang H, Xueling G, Li S, Désy L, Labrie F, Pelletier G 2006 Expression of aromatase and 17β-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study. J Steroid Biochem Mol Biol 101:136-144
36. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S 1993 Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 268:12964-12969 (Pubitemid 23182471)
37. Berstein LM, Tchernobrovkina AE, Gamajunova VB, Kovalevskij AJ, Vasilyev DA, Chepik OF, Turkevitch EA, Tsyrlina EV, Maximov SJ, Ashrafian LA, Thijssen JH 2003 Tumor estrogen content and clinicomorphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol 129:245-249
38. Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M, Lin Z 2005 Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol 95:57-62
39. Velasco I, Rueda J, Acién P 2006 Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol Hum Reprod 12:377-381
40. Sasano H, Harada N 1998 Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev 19:593-607
41. Watanabe K, Sasano H, Harada N, Ozaki M, Niikura H, Sato S, Yajima A 1995 Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol 146:491-500
42. Caillier B, Lépine J, Tojcic J, Ménard V, Perusse L, Bélanger A, Barbier O, Guillemette C 2007 A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3. Pharmacogenet Genomics 17:481-495 (Pubitemid 46905215)
43. Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, Wrighton SA 2002 Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug Metab Dispos 30:1266-1273
44. Harrington WR, Sengupta S, Katzenellenbogen BS 2006 Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology 147:3843-3850